null RI-MUHC investigator joins Global Consortium of Chemosensory Researchers (GCCR) in rapid response to COVID-19
GCCR group develops worldwide survey on smell loss
Apr. 29, 2020
Source: RI-MUHC and GCCR. Following reports from patients and clinicians about rapid onset smell loss, health organizations throughout the world have recognized anosmia as a marker for COVID-19, even in the absence of other symptoms. Scientists worldwide have united as the Global Consortium of Chemosensory Researchers (GCCR) to investigate the connection between the chemical senses and COVID-19.
Dr. Marc Tewfik, an investigator at the RI-MUHC in the Translational Research in Respiratory Diseases (RESP) Program, is part of this group of more than 500 clinicians, neurobiologists, data scientists, cognitive scientists, sensory researchers and technicians from 38 countries. The GCCR will use data collected in a worldwide survey to unravel how the virus is transmitted and how to prevent its spread. The survey will be translated to more than 20 languages and is available to individuals and clinicians on the GCCR website.
The Global Consortium of Chemosensory researchers is a group of global transdisciplinary scientists, clinicians, and patient advocates founded in response to the COVID-19 pandemic. With more than 500 members worldwide, the GCCR will harness their reach to conduct and analyze worldwide evidence-based information to combat the spread of COVID-19.